MedPath

QDENGA powder and solvent for solution for injection (Dengue tetravalent vaccine (live, attenuated))

Registration Number: MAL24026009ACZ

Approved
Approval ID

0dbc1b878c1de650

Registration Number

MAL24026009ACZ

Registration Date

Jul 7, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types2 types
Last UpdatedJul 7, 2025

PACKAGING INFORMATION (2)

1 VialsAvailable
Package Size: 1 Vials
Status: NPRA Approved
10 VialsAvailable
Package Size: 10 Vials
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (4)

Dengue virus serotype 1 (live, attenuated)Active
Monograph: dengue virus serotype 1 (live, attenuated)
Dengue virus serotype 2 (live, attenuated)Active
Monograph: dengue virus serotype 2 (live, attenuated)
Dengue virus serotype 4 (live, attenuated)Active
Monograph: dengue virus serotype 4 (live, attenuated)
Dengue virus serotype 3 (live, attenuated)Active
Monograph: dengue virus serotype 3 (live, attenuated)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

QDENGA powder and solvent for solution for injection (Dengue tetravalent vaccine (live, attenuated)) - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform